Compugroup Holding A (CMPVF) 28.7000 $CMPVF Healthcare

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Compugroup Holding A (CMPVF) 28.7000 $CMPVF

Healthcare IT Market in Saudi Arabia 2015-2019 - Emergence of Mobile Health Solutions
M2 - Wed Aug 05, 4:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ntb2ft/healthcare_it) has announced the addition of the "Healthcare IT Market in Saudi Arabia 2015-2019" report to their offering. The healthcare IT market in Saudi Arabia to grow at a CAGR of 12.28% over the period 2014-2019 Over the years, businesses in Saudi Arabia have been adopting advanced technologies and IT integration solutions to enhance their operations and revenue. With more and more operations being enabled and enriched by innovative IT applications and solutions, IT has become a key enabler of business functions. This trend is also being witnessed in the healthcare sector in Saudi Arabia. The need to maintain a standard record format has led to the transformation of traditional medical records to electronic health records. Implementation of the policy that makes insurance mandatory is also contributing to the growth of this market. The need to track common ailments has also intensified the need for IT. In addition, the inherent benefits of IT, such as process efficiency, cost-effectiveness, mobility, and accessibility are all driving its adoption. Emergence of mobile health solutions is one of the major trends upcoming in the market. Mobile devices allow healthcare providers to send information and reminders to patients, and allow doctors to monitor patients in remote locations and transmit data digitally through applications. According to the report, adoption of technology for operational effectiveness is one of the key drivers in the market. Saudi Arabia is making huge investments in cloud, mobility, virtualization, telemedicine, and remote patient monitoring. These technologies offer various benefits to healthcare solution providers. Further, the report states that advances in healthcare, coupled with a surge in pharmaceutical prices, have led to an increase in overall healthcare costs. This has deterred providers from investing in expensive IT system implementation. Key Vendors - GE Healthcare - HP - IBM - Intel - InterSystems - Oracle - Siemens Healthcare Other Prominent Vendors - 3M - Agfa healthcare - Al Faisaliah Medical Systems - BD - Bytes Technology Solutions - Cerner - Cigna Global Health - CompuGroup Medical - EIPICO - GMC - Honeywell - Nawah Healthcare - Philips Healthcare - Roche Group - TIBCO Software For more information visit http://www.researchandmarkets.com/research/nt...lthcare_it
IBM: 152.39 (+0.11), HON: 101.16 (+0.09), MDSY: 1.60 (unch), CERN: 64.08 (+0.66)

Express Medical Billing, Inc. Names CompuGroup Medical US Exclusive Partner for its Laboratory Customer Base
PR Newswire - Mon Jul 13, 2:00PM CDT
CompuGroup Medical US (CGM), developer of CGM DAQbilling(TM) and CGM LABDAQ®, has announced that it has entered into a long-term partnership with Express Medical Billing, Inc., a comprehensive medical billing company headquartered in St. Louis, Missouri. With the reach of its operations extending well across the nation, Express Medical Billing, Inc. offers highly specialized billing services to suit the needs of a wide range of medical specialties.

CompuGroup Medical US Unveils Advanced Healthcare Analytics Solution to Facilitate the Application of Predictive Science to Clinical, Administrative and Financial Operations
PR Newswire - Tue May 05, 3:30PM CDT
CompuGroup Medical US (CGM) has announced the unveiling of CGM ANALYTICS(TM), a healthcare data aggregation and analytics software solution. Built on a superior business intelligence platform, CGM ANALYTICS leverages predictive analytics to identify opportunities for improvement that are present in healthcare datasets.

European Laboratory Information System (LIS) Market 2015-2019: Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information System
M2 - Fri Mar 27, 6:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ktjw3b/european) has announced the addition of the "European Laboratory Information System (LIS) Market by Product (Integrated Laboratory Information System), by Type (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information System) - Forecast to 2019" report to their offering. The European laboratory information systems market is estimated to grow at a CAGR of 7.6% from 2014 to 2019. Germany holds a larger share of the laboratory information systems market, while the U.K. region is expected to grow at the highest CAGR of 7.7% in the forecast period. In this report, the European laboratory information systems market has been broadly classified on the basis of products, types, components, delivery mode, and end-users. The product segment is divided into standalone LIS and integrated LIS. On the basis of types, the market is segmented into clinical LIS and anatomical LIS. Based on components and delivery modes, the European LIS market is classified into services & software and on premise, remotely-hosted, and cloud-based LIS. The end-users segment includes clinical diagnostic laboratories, hospitals, anatomical pathology laboratories, blood banks, molecular diagnostic laboratories. The anatomical pathology laboratory is the fastest growing segment that is estimated to grow at the highest CAGR of 8.2% from 2014 to 2019. Factors such as increasing adoption of LIS technologies in ophthalmology, surface tissue & mucosal membrane analysis, gastrointestinal tract, and vascular system, along with the increasing need to shift towards integrated healthcare systems drive the growth of this market. The European laboratory information systems market is a competitive market with a number of market players. As of 2014, the European laboratory information systems market is majorly dominated by Cerner Corporation, Sunquest Information Systems, Inc., CompuGroup Medical AG, and Medical Information Technology, Inc. New product launches & partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the laboratory information systems market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 European Laboratory Information System (Lis) Market, By Product 6 European Laboratory Information System (Lis) Market, By Type 7 European Laboratory Information System (Lis) Market, By Component 8 European Laboratory Information System (Lis) Market, By Delivery Mode 9 European Laboratory Information System (Lis) Market, By End-User 10 European Laboratory Information System (Lis) Market, By Geography 11 European Laboratory Information System (Lis) Market: Competitive Landscape 12 Laboratory Information Systems Market, By Company - Allscripts - Cerner Corporation - Comp Pro Med - Compugroup Medical Ag - Computer Programs And Systems, Inc. - Epic Systems Corporation - Mckesson Corporation - Medical Information Technology, Inc. - Merge Healthcare Incorporated - Orchard Software Corporation - Quest Diagnostics Incorporated. - Scc Soft Computer - Siemens Healthcare (A Subsidiary Of Siemens Ag) - Sunquest Information Systems, Inc. (Subsidiary Of Roper Industries) For more information visit http://www.researchandmarkets.com/research/ktjw3b/european
ROP: 173.70 (-0.27), DGX: 63.26 (+0.26), MRGE: 7.12 (unch), CERN: 64.08 (+0.66)

Chris Lohl Accepts New Role to Oversee Research and Development for CompuGroup Medical US' Ambulatory Information Systems Division
PR Newswire - Thu Dec 18, 12:30PM CST
CompuGroup Medical US has announced that Chris Lohl, former Vice President of Research and Development (R&D) for the company's web-based products, will now oversee all R&D activities for the complete Ambulatory Information Systems (AIS) portfolio, effective immediately. Chris joined CGM over three years ago and has achieved significant milestones in enhancing the user experience for the company's innovative healthcare software solutions. Chris' success in identifying and designing new technologies to achieve the optimum user experience can be credited to his expertise and passion for innovation.

Navid Asgari Assumes New Role as Vice President of Service and Support for CompuGroup Medical US
PR Newswire - Wed Dec 03, 10:15AM CST
CompuGroup Medical US (CGM) announced today that Navid Asgari has assumed the role of Vice President of Service and Support for its Ambulatory Information Services Division (AIS), as of December 1, 2014. Navid previously held the position of Vice President of Professional Services. Navid joined CGM in the spring of 2014 and has been instrumental in the transformation of the CGM customer experience through the standardization of internal processes and the facilitation of inter-departmental collaboration aimed at driving service excellence.

Carl R. Smith Joins CompuGroup Medical US as General Manager of its Laboratory Division
PR Newswire - Tue Nov 11, 10:30AM CST
CompuGroup Medical US (CGM) announces the appointment of Carl R. Smith as General Manager of its Laboratory Division. Having held multiple leadership positions in application development, product management and client services, Carl joins CGM with over 24 years of experience in the healthcare software industry.

CompuGroup Medical US Announces Relocation of Corporate Head Office from Boston, Massachusetts to Phoenix, Arizona
PR Newswire - Fri Nov 07, 11:15AM CST
CompuGroup Medical US (CGM) has announced that effective January 1, 2015, the company's head office will be located in Phoenix, Arizona. The move will consolidate some key business units into a single location and is a strategic response to the growing demand for the company's products and services. From January 2015, the existing office at 3300 N. Central Avenue, Suite 2100 in Phoenix, Arizona, will be co-located with the new head office and will serve as a unified location for Human Resources, Research & Development, Product Management, Marketing and Sales.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 17

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 311

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 35

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 68

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 147

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 0

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Preeclampsia: Key Insights for Expecting Parents

Updated Category News Views 46

Preeclampsia: Essential Insights for Expecting Parents Preeclampsia is a significant condition that often raises concerns among expecting parents. It manifests as a dangerous form of high blood pressure during pregnancy and can also surface postpartum. Understanding this condition is vital for ensuring the health and safety of both mother and child during this crucial...

Continue Reading
DTE Energy Enhances Reliability with Smart Grid Technology

Updated Category News Views 240

DTE Energy's Progress with Smart Grid Technology DTE Energy (NYSE:DTE) has announced impressive strides in enhancing energy reliability through its cutting-edge smart grid technology. This initiative has successfully prevented nearly 5,000 power interruptions and saved over 1.8 million outage minutes for customers this year, highlighting the technology's role in ensuring...

Continue Reading
Key Insider Transactions in Major US Companies Unveiled

Updated Category News Views 270

Significant Insider Trading Activities This article sheds light on the notable insider buying and selling events reported recently, reflecting the movements within major US stocks. Major Insider Purchases Berkshire Hathaway Inc. (NYSE: BRKa) has made headlines by increasing its stake in Verisign Inc. (NASDAQ: VRSN). Under the leadership of Warren E. Buffett, the company...

Continue Reading
Hull Tactical's Latest Research Paper Enhances Market Predictions

Updated Category News Views 135

Hull Tactical Releases Innovative Academic Research The Hull Tactical team is excited to unveil its latest academic paper, titled Micro Alphas, co-authored by a talented group including Blair Hull, Petra Bakosova, Francois Cocquemas, Euan Sinclair, and Petri Fast. This research introduces a fresh framework that focuses on utilizing weak yet collectively informative...

Continue Reading
Cyrano Therapeutics and KYORIN Join Forces for Smell Loss Treatment

Updated Category News Views 138

Cyrano Therapeutics and KYORIN Collaboration Overview Cyrano Therapeutics, a pioneer in regenerative medicine, has taken a significant step forward in addressing the challenge of post-viral loss of smell. The company has entered into an option agreement with KYORIN Pharmaceutical Co., Ltd. to develop CYR-064, a promising treatment candidate specifically designed for those...

Continue Reading